TL;DR: InVision Medical Technology is a Y Combinator Summer 2022 startup AI Diagnosis of Heart Disease, currently active with a team of 2.
AI Diagnosis of Heart Disease
Last verified:
At InVision, we use AI to help streamline the interpretation of ultrasounds and identify diseases that may have been missed by human readers. Our models have been tightly integrated into the clinical workflow to allow easy usage by clinicians. Our work has previously been peer-reviewed and published in several top medical venues, including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), JAMA Cardiology (2022). Results from our blinded and randomized clinical trial on evaluating cardiac function have also been recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology.
Built by LemStudio
Yes. InVision Medical Technology was funded by Y Combinator in the Summer 2022 batch. AI Diagnosis of Heart Disease
At InVision, we use AI to help streamline the interpretation of ultrasounds and identify diseases that may have been missed by human readers. Our models have been tightly integrated into the clinical workflow to allow easy usage by clinicians. Our work has previously been peer-reviewed and published in several top med…
InVision Medical Technology was part of Y Combinator's Summer 2022 batch.
InVision Medical Technology has a team of 2 people according to Y Combinator's directory.
InVision Medical Technology is currently listed as Active with a team of 2 in Y Combinator's directory.
Loading interactive view…